Aclaris Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Aclaris Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$10.5M, a 66.8% increase year-over-year.
  • Aclaris Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$46.3M, a 62.2% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$97.4M, a 8.35% decline from 2022.
  • Aclaris Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$89.9M, a 0.15% decline from 2021.
  • Aclaris Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$89.7M, a 76.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$97.4M -$7.5M -8.35% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$89.9M -$131K -0.15% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$89.7M -$38.8M -76.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$50.9M +$60.1M +54.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$111M -$26.3M -31% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$84.8M -$30.4M -56% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$54.4M -$5.79M -11.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 -$48.6M -$27.9M -135% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 -$20.7M -$12.1M -142% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$8.53M -$3.28M -62.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 -$5.26M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.